CapWealth Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,020
Closed -$212K 102
2019
Q2
$212K Sell
2,020
-33
-2% -$3.32K 0.03% 93
2019
Q1
$217K Buy
+2,053
New +$206K 0.03% 92
2018
Q4
Sell
-2,188
Closed -$223K 106
2018
Q3
$223K Buy
+2,188
New +$211K 0.04% 103
2018
Q1
Sell
-2,841
Closed -$200K 104
2017
Q4
$200K Sell
2,841
-1,213
-30% -$87.5K 0.04% 96
2017
Q3
$253K Sell
4,054
-1,439
-26% -$85.2K 0.05% 92
2017
Q2
$315K Sell
5,493
-2,502
-31% -$147K 0.06% 86
2017
Q1
$486K Sell
7,995
-2,416
-23% -$137K 0.1% 80
2016
Q4
$571K Sell
10,411
-1,468
-12% -$70.4K 0.12% 70
2016
Q3
$548K Sell
11,879
-4,102
-26% -$173K 0.13% 67
2016
Q2
$544K Buy
+15,981
New +$499K 0.13% 67

Other funds holding NGVT

CapWealth Advisors's NGVT Position: Q3 2019 in Review

CapWealth Advisors sold out of Ingevity (NGVT) in Q3 2019, closing a stake of 2,020 shares — an estimated $212K sold.

CapWealth Advisors first reported a position in NGVT in Q2 2016 and held it in 10 quarters. The position peaked at $571K in Q4 2016. 335 funds tracked by Wall St. Rank hold NGVT as of Q3 2019.

  • CapWealth Advisors reported no remaining Ingevity position as of Q3 2019 after selling out during the quarter.
  • CapWealth Advisors sold 2,020 Ingevity shares in Q3 2019, an estimated $212K.
  • CapWealth Advisors first reported a position in Ingevity in Q2 2016 and held it in 10 quarters.
  • CapWealth Advisors's Ingevity position peaked at $571K in Q4 2016.
  • 335 funds tracked by Wall St. Rank held Ingevity as of Q3 2019.

Based on CapWealth Advisors's 13F filing for Q3 2019, filed 29 Oct 2019.